DRKS00025497招募中不适用

Viral load of SARS-CoV-2 in gas from pneumoperitoneum in minimally invasive surgery compared to open surgery - SARCOMIS

Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Universitätsklinikum Heidelberg0 个研究点目标入组 80 人开始时间: 2021年6月22日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Patients with confirmed SARS-CoV-2 infection with an urgent need for either minimally invasive or open visceral or general surgery will be included in the study. Patients agree to participate by signing and dating the informed consent form before the surgical procedure. It is planned to take samples from patients with SARS-CoV-2 infection who, due to the urgency of immediate medical or surgical treatment, or at the time of the intervention or sampling, are sedated, ventilated, or unstable and therefore unable to give consent at the time. The taking of the samples and participation in the study is determined by detailed information of the patient's representative. The informed consent is then carried out with the representative in the same way as with the patient. The patient will be informed accordingly after the ability to consent has been regained. The patients can withdraw their consent at any time. In the event of revocation, the biomaterials and data obtained will be destroyed and deleted accordingly. Only those patients without SARS-CoV-2 infection who are capable of giving consent will be included in the study. The patient's age of majority is a prerequisite for participating in the study.

发起方

Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Universitätsklinikum Heidelberg